Pharmacology of T-Cell Therapies, Volume 106 in the Advances in Pharmacology series, highlights new advances in the field, with this new volume presenting interesting chapters written by an international board of authors. Topics in this new release include Enhancing persistence of therapeutic T cells, T cell manufacturing impacts on in vivo function, Transient T cell therapies, In vivo T cell therapies, T cell subsets for therapy, Engineering T cell metabolism to enhance therapeutic efficacy, and Tracking Therapeutic T cells In Vivo contacts.
Table of Contents
1. Enhancing persistence of therapeutic T cells Greg Chen 2. T cell manufacturing impacts on in vivo function Xiao Huang 3. Transient T cell therapies Xuexiang Han and Mike Mitchel 4. In vivo T cell therapies Saar Gill 5. T cell subsets for therapy Antonia ROTOLO 6. Engineering T cell metabolism to enhance therapeutic efficacy Roderick O’Connor and Laura Anderson 7. Tracking Therapeutic T cells In Vivo contacts Mark Sellmyer and Angela Gong
The sample excerpt is provided to help you make an informed purchasing decision. It is not intended to serve as free content or replace a full report. To ensure the sample aligns with your specific needs, our team will contact you to better understand your requirements.
An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net
This report can be tailored to focus on a specific country, region, continent, or provide global coverage. Please indicate your regions of interest and share any additional questions you may have. Our team strives to respond to all inquiries within the same business day.
An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net